COST Action CA17140

This website is based upon work from COST Action CA17140 (Nano2Clinic), supported by COST (European Cooperation in Science and Technology)

The following links access information about this Action on the COST website.

Officers

Chair of the Action:
Prof Barbara KLAJNERT-MACULEWICZ

Vice Chair of the Action:
Prof Sabrina PRICL

Science officer of the Action:
Dr Luule MIZERA

View the Management Committee

News

Special Issue of Pharmaceutics dedicated to our Action - extension of deadline for paper submission

Dear COSTers,

As the Guest Editor of the Special Issue of Pharmaceutics (IF 4.421) “Cancer Nanomedicine—From the Bench to the...

CURRENT CHALLENGES IN GLIOBLASTOMA THERAPY - OPEN MEETING

Dear COSTers,

you are cordially invited to partipate to the upcoming open meeting on "CURRENT CHALLENGES IN GLIOBLASTOMA THERAPY", organized...

#ETPN2020 - 15th annual event of the European Technology Platform on Nanomedicine

Dear COSTers,

ETPN2020 is a virtual conference bringing together scientists, technology providers, entrepreneurs, industry and clinicians, all of them developing...